Fingerprint
Dive into the research topics of 'A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically